📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension (2019)

First Author: Arnold N

Attributed to: Investigation of MiR-140-5p in Humans and Experimental Models of Pulmonary Arterial Hypertension. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-019-13139-9

PubMed Identifier: 31729368

Publication URI: http://europepmc.org/abstract/MED/31729368

Type: Journal Article/Review

Parent Publication: Nature Communications

Issue: 1

ISSN: 2041-1723